Arrowhead Research reported $-24054000 in Operating Profit for its fourth fiscal quarter of 2020.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Profit Change
Agios Pharmaceuticals AGIO:US $ -92.43M 2.11M
Alnylam Pharmaceuticals ALNY:US $ -194.22M 30.98M
Arena Pharmaceuticals ARNA:US $ -122.35M 23.54M
Arrowhead Research ARWR:US $ -24054000 26.07M
Bluebird Bio BLUE:US $ -203.98M 14.29M
Cerulean Pharma CERU:US $ -7581820 455.99K
Dicerna Pharmaceuticals DRNA:US $ -31.65M 8.75M
Heron Therapeutics HRTX:US $ -61.3M 2.91M
Intercept Pharmaceuticals ICPT:US $ -40.6M 14.56M
Ligand Pharmaceuticals LGND:US $ 11.21M 7.46M
Merk MRK:US $ -2249M 5365M
Mirati Therapeutics MRTX:US $ -106.34M 17.66M
Moderna Inc MRNA:US -275038000 39.92M
Nektar Therapeutics NKTR:US $ -110.72M 7.67M
Novartis NOVN:VX 2.64B 232M
Opko Health OPK:US $ 49.36M 27.42M
Spectrum Pharmaceuticals SPPI:US $ -39.57M 3.08M
Ultragenyx Pharmaceutical RARE:US $ -96.08M 45.77M
Vertex Pharmaceuticals VRTX:US $ 745.79M 73.55M
Xencor XNCR:US $ -13.7M 3.02M
YTE INCY:US $ 164.23M 158.9M